IRNO CONSALVO, MARIA ANTONIETTA
IRNO CONSALVO, MARIA ANTONIETTA
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting
2020-04-02 Hanekamp, D; Snel, An; Kelder, A; Scholten, Wj; Khan, N; Metzner, M; Irno-Consalvo, M; Sugita, M; de Jong, A; Oude Alink, S; Eidhof, H; Wilhelm, M; Feuring-Buske, M; Slomp, J; van der Velden, Vhj; Sonneveld, E; Guzman, M; Roboz, Gj; Buccisano, F; Vyas, P; Freeman, S; Bachas, C; Ossenkoppele, Gj; Schuurhuis, Gj; Cloos, J
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia
2021-11-21 Palmieri, R; Buccisano, F; Arena, V; Irno Consalvo, Ma; Piciocchi, A; Maurillo, L; Delprincipe, Mi; Di Veroli, A; Paterno, G; Conti, C; Fraboni, D; Voso, Mt; Arcese, W; Venditti, A
Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells
2020-08-25 Travaglini, S; Angelini, Df; Alfonso, V; Guerrera, G; Lavorgna, S; Divona, M; Nardozza, Am; Consalvo, Mi; Fabiani, E; De Bardi, M; Neri, B; Forghieri, F; Marchesi, F; Paterno, G; Cerretti, R; Barragan, E; Fiori, V; Dominici, S; Del Principe, Mi; Venditti, A; Battistini, L; Arcese, W; Lo-Coco, F; Voso, Mt; Ottone, T
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the campus all network
2021-01-01 Del Principe, Mi; Buzzatti, E; Piciocchi, A; Forghieri, F; Bonifacio, M; Lessi, F; Imbergamo, S; Orciuolo, E; Rossi, G; Fracchiolla, N; Trappolini, S; Neri, B; Sarlo, C; Zappasodi, P; Dargenio, M; Cefalo, M; Irno-Consalvo, Ma; Conti, C; Paterno, G; De Angelis, G; Sciumè, M; Della Starza, I; Venditti, A; Foà, R; Guarini, Ar
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment
2022-10-14 Sconocchia, G; Lanzilli, G; Cesarini, V; Silvestris, Da; Rezvani, K; Arriga, R; Caratelli, S; Chen, K; Dou, J; Cenciarelli, C; Toietta, G; Baldari, S; Sconocchia, T; De Paolis, F; Aureli, A; Iezzi, G; Irno Consalvo, M; Buccisano, F; del Principe, Mi; Maurillo, L; Venditti, A; Ottaviani, A; Spagnoli, Gc
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
2022-01-01 Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Capria, S; Maurillo, L; Del Principe, Mi; Paterno, G; Irno Consalvo, Ma; Ottone, T; Lavorgna, S; Voso, Mt; Fazi, P; Vignetti, M; Arcese, W; Venditti, A
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways
2023-10-06 Ottone, T; Silvestrini, G; Piazza, R; Travaglini, S; Gurnari, C; Marchesi, F; Nardozza, Am; Fabiani, E; Attardi, E; Guarnera, L; Divona, M; Ricci, P; Irno Consalvo, Ma; Ienzi, S; Arcese, R; Biagi, A; Fiori, L; Novello, M; Mauriello, A; Venditti, A; Anemona, L; Voso, Mt
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia
2019-09-19 Venditti, A; Piciocchi, A; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; de Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Mazza, P; Martelli, Mp; Cuneo, A; Albano, F; Fabbiano, F; Tafuri, A; Chierichini, A; Tieghi, A; Fracchiolla, Ns; Capelli, D; Foà, R; Alati, C; La Sala, E; Fazi, P; Vignetti, M; Maurillo, L; Buccisano, F; Del Principe, Mi; Irno-Consalvo, M; Ottone, T; Lavorgna, S; Voso, Mt; Lo-Coco, F; Arcese, W; Amadori, S
Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome
2018-01-01 Del Principe, Mi; Buccisano, F; Soddu, S; Maurillo, L; Cefalo, M; Piciocchi, A; Consalvo, Mi; Paterno, G; Sarlo, C; De Bellis, E; Zizzari, A; De Angelis, G; Fraboni, D; Divona, M; Voso, Mt; Sconocchia, G; Del Poeta, G; Lo-Coco, F; Arcese, W; Amadori, S; Venditti, A
Longitudinal detection of DNMT3AR882Htranscripts in patients with acute myeloid leukemia
2018-02-08 Ottone, T; Alfonso, V; Iaccarino, L; Hasan, Sk; Mancini, M; Divona, M; Lavorgna, S; Cicconi, L; Panetta, P; Maurillo, L; Del Principe, Mi; Irno Consalvo, M; Franceschini, L; Angelini, Df; Battistini, L; Guerrera, G; DE BARDI, M; Fabiani, E; Falconi, G; Arcese, W; Amadori, S; Buccisano, F; Venditti, A; Voso, Mt; Lo-Coco, F
Risk-adapted MRD-directed therapy for young acute myeloid leukemia adults: 6-year update of the GIMEMA AML1310 trial
2024-07-05 Venditti, A; Piciocchi, A; Candoni, A; Arena, V; Palmieri, R; Fili, C; Carella, Am; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Curti, A; Luppi, M; Ingrosso, C; Martelli, Mp; Cuneo, A; Albano, F; Mulè, A; Tafuri, A; Cudillo, L; Tieghi, A; Fracchiolla, Ns; Capelli, D; Trisolini, Sm; Alati, C; La Sala, E; Maurillo, L; Del Principe, Mi; Irno Consalvo, Ma; Divona, Md; Ottone, T; Cerretti, R; Sconocchia, G; Voso, Mt; Fazi, P; Vignetti, M; Buccisano, F
The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation.
2018-06-01 Faraoni, I; Aloisio, F; De Gabrieli, A; Irno Consalvo, M; Lavorgna, S; Voso, M; Lo-Coco, F; Graziani, G
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation
2021-03-03 Buccisano, F; Palmieri, R; Piciocchi, A; Maurillo, L; Del Principe, Mi; Paterno, G; Soddu, S; Cerretti, R; De Angelis, G; Mariotti, B; Irno Consalvo, Ma; Conti, C; Fraboni, D; Divona, M; Ottone, T; Lavorgna, S; Panetta, P; Voso, Mt; Arcese, W; Venditti, A
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 2-apr-2020 | Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting | Hanekamp, D; Snel, An; Kelder, A; Scholten, Wj; Khan, N; Metzner, M; Irno-Consalvo, M; Sugita, M; de Jong, A; Oude Alink, S; Eidhof, H; Wilhelm, M; Feuring-Buske, M; Slomp, J; van der Velden, Vhj; Sonneveld, E; Guzman, M; Roboz, Gj; Buccisano, F; Vyas, P; Freeman, S; Bachas, C; Ossenkoppele, Gj; Schuurhuis, Gj; Cloos, J | Articolo su rivista | |
| 21-nov-2021 | CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia | Palmieri, R; Buccisano, F; Arena, V; Irno Consalvo, Ma; Piciocchi, A; Maurillo, L; Delprincipe, Mi; Di Veroli, A; Paterno, G; Conti, C; Fraboni, D; Voso, Mt; Arcese, W; Venditti, A | Articolo su rivista | |
| 25-ago-2020 | Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells | Travaglini, S; Angelini, Df; Alfonso, V; Guerrera, G; Lavorgna, S; Divona, M; Nardozza, Am; Consalvo, Mi; Fabiani, E; De Bardi, M; Neri, B; Forghieri, F; Marchesi, F; Paterno, G; Cerretti, R; Barragan, E; Fiori, V; Dominici, S; Del Principe, Mi; Venditti, A; Battistini, L; Arcese, W; Lo-Coco, F; Voso, Mt; Ottone, T | Articolo su rivista | |
| 1-gen-2021 | Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the campus all network | Del Principe, Mi; Buzzatti, E; Piciocchi, A; Forghieri, F; Bonifacio, M; Lessi, F; Imbergamo, S; Orciuolo, E; Rossi, G; Fracchiolla, N; Trappolini, S; Neri, B; Sarlo, C; Zappasodi, P; Dargenio, M; Cefalo, M; Irno-Consalvo, Ma; Conti, C; Paterno, G; De Angelis, G; Sciumè, M; Della Starza, I; Venditti, A; Foà, R; Guarini, Ar | Articolo su rivista | |
| 14-ott-2022 | Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment | Sconocchia, G; Lanzilli, G; Cesarini, V; Silvestris, Da; Rezvani, K; Arriga, R; Caratelli, S; Chen, K; Dou, J; Cenciarelli, C; Toietta, G; Baldari, S; Sconocchia, T; De Paolis, F; Aureli, A; Iezzi, G; Irno Consalvo, M; Buccisano, F; del Principe, Mi; Maurillo, L; Venditti, A; Ottaviani, A; Spagnoli, Gc | Articolo su rivista | |
| 1-gen-2022 | ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol | Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Capria, S; Maurillo, L; Del Principe, Mi; Paterno, G; Irno Consalvo, Ma; Ottone, T; Lavorgna, S; Voso, Mt; Fazi, P; Vignetti, M; Arcese, W; Venditti, A | Articolo su rivista | |
| 6-ott-2023 | Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways | Ottone, T; Silvestrini, G; Piazza, R; Travaglini, S; Gurnari, C; Marchesi, F; Nardozza, Am; Fabiani, E; Attardi, E; Guarnera, L; Divona, M; Ricci, P; Irno Consalvo, Ma; Ienzi, S; Arcese, R; Biagi, A; Fiori, L; Novello, M; Mauriello, A; Venditti, A; Anemona, L; Voso, Mt | Articolo su rivista | |
| 19-set-2019 | GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia | Venditti, A; Piciocchi, A; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; de Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Mazza, P; Martelli, Mp; Cuneo, A; Albano, F; Fabbiano, F; Tafuri, A; Chierichini, A; Tieghi, A; Fracchiolla, Ns; Capelli, D; Foà, R; Alati, C; La Sala, E; Fazi, P; Vignetti, M; Maurillo, L; Buccisano, F; Del Principe, Mi; Irno-Consalvo, M; Ottone, T; Lavorgna, S; Voso, Mt; Lo-Coco, F; Arcese, W; Amadori, S | Articolo su rivista | |
| 1-gen-2018 | Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome | Del Principe, Mi; Buccisano, F; Soddu, S; Maurillo, L; Cefalo, M; Piciocchi, A; Consalvo, Mi; Paterno, G; Sarlo, C; De Bellis, E; Zizzari, A; De Angelis, G; Fraboni, D; Divona, M; Voso, Mt; Sconocchia, G; Del Poeta, G; Lo-Coco, F; Arcese, W; Amadori, S; Venditti, A | Articolo su rivista | |
| 8-feb-2018 | Longitudinal detection of DNMT3AR882Htranscripts in patients with acute myeloid leukemia | Ottone, T; Alfonso, V; Iaccarino, L; Hasan, Sk; Mancini, M; Divona, M; Lavorgna, S; Cicconi, L; Panetta, P; Maurillo, L; Del Principe, Mi; Irno Consalvo, M; Franceschini, L; Angelini, Df; Battistini, L; Guerrera, G; DE BARDI, M; Fabiani, E; Falconi, G; Arcese, W; Amadori, S; Buccisano, F; Venditti, A; Voso, Mt; Lo-Coco, F | Articolo su rivista | |
| 5-lug-2024 | Risk-adapted MRD-directed therapy for young acute myeloid leukemia adults: 6-year update of the GIMEMA AML1310 trial | Venditti, A; Piciocchi, A; Candoni, A; Arena, V; Palmieri, R; Fili, C; Carella, Am; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Curti, A; Luppi, M; Ingrosso, C; Martelli, Mp; Cuneo, A; Albano, F; Mulè, A; Tafuri, A; Cudillo, L; Tieghi, A; Fracchiolla, Ns; Capelli, D; Trisolini, Sm; Alati, C; La Sala, E; Maurillo, L; Del Principe, Mi; Irno Consalvo, Ma; Divona, Md; Ottone, T; Cerretti, R; Sconocchia, G; Voso, Mt; Fazi, P; Vignetti, M; Buccisano, F | Articolo su rivista | |
| 1-giu-2018 | The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation. | Faraoni, I; Aloisio, F; De Gabrieli, A; Irno Consalvo, M; Lavorgna, S; Voso, M; Lo-Coco, F; Graziani, G | Articolo su rivista | |
| 3-mar-2021 | Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation | Buccisano, F; Palmieri, R; Piciocchi, A; Maurillo, L; Del Principe, Mi; Paterno, G; Soddu, S; Cerretti, R; De Angelis, G; Mariotti, B; Irno Consalvo, Ma; Conti, C; Fraboni, D; Divona, M; Ottone, T; Lavorgna, S; Panetta, P; Voso, Mt; Arcese, W; Venditti, A | Articolo su rivista |